Physiological consequences of ectopic agouti gene expression: The yellow obese mouse syndrome

Physiological Genomics

Volumn 1999, Issue 1, 1999, Pages 151-163

  Wolff, George L ^a,b,d   Roberts, Dean W ^b   Mountjoy, Kathleen G ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Background genome; Melanocortin; Pseudoagouti mice; Response to environmental stimuli; Tumorigenesis

Indexed keywords

AGOUTI;

AGOUTI PROTEIN; PROTEIN; SIGNAL PEPTIDE;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HAIR COLOR; MOUSE; OBESITY; PATHOLOGY; REVIEW; SYNDROME;

ANIMALS; GENE EXPRESSION REGULATION; HAIR COLOR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OBESITY; PROTEINS; SYNDROME;

EID: 0033547260     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.1999.1.3.151     Document Type: Review

References (49)

1. Aberdam, E., C. Bertolotto, E. V. Sviderskaya, V. de Thillot, T. J. Hemesath, D. E. Fisher, D. C. Bennett, J. P. Ortonne, and R. Ballotti. Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J. Biol. Chem. 273: 19560-19565, 1998.
2. Bultman, S. J., E. J. Michaud, and R. P. Woychik. Molecular characterization of the mouse agouti locus. Cell 71: 1195-1204, 1992.
3. viable yellow/a) mice. Pharmacol. Biochem. Behav. 53: 425-432, 1996.
4. Cone, R. D., D. Lu, S. Koppula, D. I. Vage, H. Klungland, B. Boston, W. Chen, D. N. Orth, C. Pouton, and R. A. Kesterson. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog. Horm. Res. 51: 287-318, 1996.
5. Cuénot, L. Les races pures et leur combinaisons chez les souris. Arch. Zool. Expér. Géner. 3: 123-132, 1905.
6. Dickie, M. M. A new viable yellow mutation in the house mouse. J. Hered. 53: 84-86, 1962.
7. Engström, K. G., K. Grankvist, and I.-B. Täljedal. Insulin-driven erythropoeisis may underlie impairment of erythrocyte deformability in hyperinsulinaemic, hyperglycaemic ob/ob mice. Diabetologia 33: 127-130, 1990.
8. Finkelstein, J. A., P. Jervois, M. Menadue, and J. O. Willoughby. Growth hormone and prolactin secretion in genetically obese Zucker rats. Endocrinology 118: 1233-1236, 1986.
9. vy/A and agouti A/a (BALB/c × VY)F-1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. Intl. J. Obesity 12: 305-320, 1988.
10. Gunn, T. M., K. A. Miller, L. He, R. W. Hyman, R. W. Davis, A. Azarani, S. F. Schlossman, J. S. Duke-Cohan, and G. S. Barsh. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398: 152-156, 1999.
11. vy) of the mouse agouti locus. Mol. Carcinog. 15: 70-80, 1996.
12. Huszar, D., C. A. Lynch, V. Fairchild-Huntress, J. H. Dunmore, Q. Fang, L. R. Berkemeier, W.-Gu, R. A. Kesterson, B. A. Boston, R. D. Cone, F. J. Smith, L. A. Campfield, P. Burn, and F. Lee. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.
13. Lord, G. M., G. Matareses, L. L. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901, 1998.
14. Maffei, M., J. Halaas, E. Ravussin, R. E. Pratley, G. H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, P. A. Kern, and J. M. Friedman. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1: 1155-1161, 1995.
15. Manne, J., A. C. Argeson, and L. D. Siracusa. Mechanisms for the pleiotropic effects of the agouti gene. Proc. Natl. Acad. Sci. USA 92: 4721-4724, 1995.
16. Mendel, V. E. Influence of the insulin-to-growth hormone ratio on body composition of mice. Am. J. Physiol. 238 (Endocrinol. Metab. 1): E231-E234, 1980.
17. y) is associated with the disruption of a novel RNA-binding protein. Genes Dev. 7: 1203-1213, 1993.
18. iapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev. 8: 1463-1472, 1994.
19. Mynatt, R. L., R. J. Miltenberger, M. L. Klebig, M. B. Zemel, J. E. Wilkinson, W. O. Wilkinson, and R. P. Woychik. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc. Natl. Acad. Sci. USA 94: 919-922, 1997.
20. Nagle, D. L., S. H. McGrail, J. Vitale, E. A. Woolf, B. L. Dussault, Jr., L. DiRocco, L. Holmgren, J. Montagno, P. Bork, D. Huszar, V. Fairchild-Huntress, P. Ge, J. Keilty, C. Ebeling, L. Baldini, J. Gilchrist, P. Burn, G. A. Karlson, and K. J. Moore. The mahogany protein is a receptor involved in suppression of obesity. Nature 398: 148-152, 1999.
21. Oberbauer, A. M, J. S. Stern, P. R. Johnson, B. A. Horwitz, J. B. German, S. D. Phinney, D. H. Beermann, D. Pomp, and J. D. Murray. Body composition of inactivated growth hormone (OMT1A-oGH) transgenic mice - generation of an obese phenotype. Growth Dev. Aging 61: 169-179, 1997.
22. Ollmann, M. M., B. D. Wilson, Y. K. Yang, J. A. Kerns, Y. Chen, I. Gantz, and G. S. Barsh. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135-138, 1997.
23. Pogribny I. P., A. G. Basnakian, B. J. Miller, N. G. Lopatina, L. A. Poirier, and S. J. James. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res. 55: 1894-1901, 1995.
24. vy/a) mice (Abstract). Toxicologist 4: 110, 1984.
25. Roberts, D. W., and W. P. Weidanz. Splenomegaly, enhanced phagocytosis and anemia are thymus dependent responses to malaria. Infect. Immun. 20: 728-731, 1978.
26. vy/a mice. Proc. Natl. Acad. Sci. USA 81: 2152-2156, 1984.
27. Schrauwen, P., K. Walder, and E. Ravussin. Human uncoupling proteins and obesity. Obesity Res. 7: 97-105, 1999.
28. Shimizu, H., N. S. Shargill, and G. A. Bray. Adrenalectomy and response to corticosterone and α-MSH in the genetically obese yellow mouse. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R494-R500, 1989.
29. Star, R. A., N. Rajora, J. Huang, R. C. Stock, A. Catania, and J. M. Lipton. Evidence of autocrine modulation of macrophage nitric oxide synthase by a-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA 92: 8016-8020, 1995.
30. vy/-mice: Relation to adult hyperinsulinemia and obesity. Proc. Soc. Biol. Med. 206: 145-151, 1994.
31. Whittaker, P., V. C. Dunkel, T. J. Bucci, D. F. Kusewitt, J. D. Thurman, A. Warbritton, and G. L. Wolff. Genome-linked toxic responses to dietary iron overload. Toxicol. Pathol. 25: 556-564, 1997.
32. Willard, D. H., W. Bodnar, C. Harris, L. Kiefer, J. S. Nichols, S. Blanchard, C. Hoffman, M. Moyer, W. Burkhart, J. Weiel, M. A. Luther, W. O. Wilkison, and W. J. Rocque. Agouti structure and function: characterization of a potent α-melanocyte-stimulating hormone receptor antagonist. Biochemistry 34: 12341-12346, 1995.
33. Wilson, B. D., M. M. Ollmann, L. Kang, M. Stoffel, G. I. Bell, and G. S. Barsh. Structure and function of ASP, the human homolog of the mouse agouti gene. Hum. Mol. Genet. 4: 223-230, 1995.
34. Wolff, G. L. Genetic influences on response to castration of liver growth and hepatoma formation. Cancer Res. 30: 1726-1730, 1970.
35. Wolff, G. L. Genetic modification of homeostatic regulation in the mouse. Am. Nat. 105: 241-252, 1971.
36. Wolff, G. L. Body weight and cancer. Am. J. Clin. Nutr. 45: 168-180, 1987.
37. vy/a genotype in obese and lean mice. In: Progress in Obesity Research, 1990, edited by Y. Oomura, S. Tarui, S. Inoui, and T. Shimazu. London: John Libbey, 1991, p. 445-448.
38. Wolff, G. L. Variability in gene expression and tumor formation within genetically homogeneous animal populations in bioassays. Fund. Appl. Tox. 29: 176-184, 1996.
39. Wolff, G. L., and J. D. Flack. Genetic regulation of plasma corticosterone concentration and its response to castration and allogeneic tumor growth. Nat. New Biol. 232: 181-182, 1971.
40. Wolff, G. L., D. L. Greenman, L. G. Frigeri, R. L. Morrissey, R. L. Suber, and R. P. Felton. Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c × VY)F-1 hybrid mice. Proc. Soc. Exp. Biol. Med. 193: 155-163, 1990.
41. Wolff, G. L., R. L. Kodell, J. A. Kaput, and W. J. Visek. Caloric restriction abolishes enhanced metabolic efficiency induced by ectopic agouti protein in yellow mice. Proc. Soc. Exp. Biol. Med. 221: 99-104, 1999.
42. vy/a mice. FASEB J. 12: 949-957, 1998.
43. Wolff, G. L., and H. C. Pitot. Variation of hepatic malic enzyme capacity with hepatoma susceptibility in mice of different genotypes. Cancer Res. 32: 1861-1863, 1972.
44. vy/a mice: The yellow mouse syndrome. J. Hered. 77: 151-158, 1986.
45. Wolff, G. L., D. W. Roberts, R. L. Morrissey, D. L. Greenman, R. R. Allen, W. Campbell, H. Bergman, S. Nesnow, and C. H. Frith. Tumorigenic response to lindane in mice: potentiation by a dominant mutation. Carcinogenesis 8: 1889-1897, 1987.
46. Wright, S. Physiological and evolutionary theories of dominance. Am. Nat. 68: 25-53, 1934.
47. Wright, S. The physiology of the gene. Physiol. Rev. 21: 487-527, 1941.
48. vy/-mice: ectopic expression of the agouti gene. FASEB J. 8: 479-488, 1994.
49. Zemel, M. B. Agouti/melanocortin interactions with leptin pathways in obesity. Nutr. Rev. 56: 271-274, 1998.